MiR-378 is preferentially expressed in cardiomyocytes but not in cardiac fibroblasts
We performed a northern blot analysis of multiple mouse tissues and found that miR-378 is the most highly expressed in the heart and skeletal muscle (Sup. Figure 3A) , which was also confirmed by realtime PCR (Sup. Figure 3B ). By using real-time PCR we found that miR-378 was preferentially expressed in cardiomyocytes and had no expression in cardiac fibroblasts from neonatal rat hearts. We then examined the miR-378 expression in the cardiomyocytes and cardiac fibroblasts from both the adult wildtype mouse hearts and miR-378 knockout mouse hearts under sham and TAC conditions. In the sham-operated adult mice, we found that miR-378 had high expression in cardiomyocytes but had decreased expression in that of the miR-378 KO (+/-) mice, and we did not detect the expression of miR-378 in cardiac fibroblasts. In the TAC-operated mouse hearts, we surprisingly detected the expression of miR-378 in cardiac fibroblasts of wild-type mice, which may be originated from the caridomyocytes by paracrine mechanism under mechanical force (Sup. Figure 3C ).
Supplemental Tables and Figures
Sup. KO represents miR-378 knockout mice(+/-). All the adult mice underwent 2 weeks TAC. In the shamoperated adult mice, we found that miR-378 had high expression in cardiomyocytes but had decreased expression in that of the miR-378 KO (+/-) mice, and we did not detect the expression of miR-378 in cardiac fibroblasts. In the TAC-operated mouse hearts, we surprisingly detected the expression of miR-378 in cardiac fibroblasts of wild-type mice, which may be originated from the caridomyocytes by paracrine mechanism under mechanical force. control; ##, P< 0.05 vs. control with MS for 24hr. Western blot of heart isolated from miR-378 KO (+/-) and WT mice using antibody against PGC-1β.
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GAPDH was used as a loading control.
Sup. Figure 8
The shows expression of miR-378 in serum and (B) shows EF% value in healthy control subjects(n=28), HF cases (NT-proBNP<2000) (n=12), and HF cases (NT-proBNP>2000) (n=15). Values represent the mean ± SE. **, P< 0.01 vs. healthy control; *, P< 0.05 vs. healthy control; ##, P< 0.01 vs. HF (BNP<2000).
Then HF patients were categorized according their miR-378 levels in serum at the dividing point of 200
copies. (C) and (D) show blood NT-proBNP levels and EF% value in healthy controls (n=28), HF cases (miR-378>200) (n=11), and HF cases (miR-378<200) (n=16). Values represent the mean ± SE. **, P< 0.01 vs. healthy control; ##, P< 0.01 vs. HF (miR-378>200); #, P< 0.05 vs. HF (miR-378>200).
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Supplemental Experimental Procedures
Clinical study cohort
Following ethical approval and informed consent, venous blood samples were collected from participants, including HF patients (n=27) and healthy controls (n=28). Experiments described were performed on samples obtained at Shanghai Zhongshan hospital at the time of diagnosis. All provided written consent and Ethic permission. In this study, we classified subjects as HF cases when they met the Framingham criteria for the diagnosis and NYHA class is above class I.
Analysis of miR-378 gene expression in human serum
Whole blood was separated into serum within 4h after blood was derived. For serum RNA isolation, equal volume of Trizol was used, and additional two more steps of phenol/chloroform purification since serum is full of proteins. The RNA concentration was determined using a NanoDrop spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE). The expression level of miR-378 was analyzed with a Taqman-based real-time quantitative PCR (RT-qPCR) using individual miRNA-specific primers and probes according to the manufacturer's protocol (Applied Biosystems). The first-strand miRNA-cDNA PCR template was reverse transcribed from 100 ng of total RNA using the TaqMan® MicroRNA Reverse
Transcription Kit (Applied Biosystems). Synthetic standard mature miR-378 were also included in each batch of reactions. PCR reactions were carried out in final volumes of 10 μl using an ABI 7900 HT Fast
Real-Time PCR System (Applied Biosystems). Reaction programs were performed according to the instruction, reactions were initiated with a 10-minute incubation at 95°C followed by 40 cycles at 95°C
for 15 seconds and 60°C for 60 seconds. We quantified the mature miR-378 through standard curve.
Standard curves were generated for miR-378 assay using a dilution series of known input amounts of synthetic oligonucleotide. Raw PCR data (Ct values) were transformed into miR-378 copy numbers per RT reaction by SDS (Applied Biosystems) through extrapolation to the miR-378 standard curve (copies/ng).
Mouse TAC models
All animal procedures were approved by the Animal Care and Use Committee of Fudan University, and in compliance with guidelines for the Care and Use of Laboratory Animals published by the National Academy Press (NIH Publication No. 85-23, revised 1996) . Adult mice were anesthetized via isoflurane inhalation and transferred to a heat-controlled pad to maintain a constant body temperature. Strong pressure overload was imposed on the heart of mice by TAC using a 27-gauge needle as described previously. (Zou et al., 2011) MiR-378 agomirs and miR-378 antagomirs were synthesized as described. (Krutzfeldt et al., 2005; van Solingen et al., 2009 ) Administration of intravenous injections started at the first day after TAC on three consecutive days (each 80mg/kg body weight). Transthoracic echocardiographic was performed with the use of Vevo770 echocardiograph (VisualSonics, Canada).
Two-dimensional M-mode echocardiographic examination were performed using a 30MHz linear transducer at a stable heart rate of 500 beats/min. Haemodynamic measurements were performed by inserting a micronanometer catheter (Millar 1.4F, Millar Instruments) from the right common carotid artery. The transducer was connected to Power Laboratory system (AD Instruments) and blood pressure (BP) was measured. Animals in sham groups without elevation of BP (100~120 mmHg) and in TAC groups with elevation of BP by 40~50 mmHg were enclosed. Mice were sacrificed immediately after measurements and hearts were removed and weighed, quickly frozen in liquid nitrogen, and stored at -80℃.
Knockout mouse generation
Single-guide RNA (sgRNA) was designed by an online CRISPR Design Tool (http://tools.genomeengineering.org). To generate the sgRNA expression construct, vector pUC57-sgRNA (51132;
Addgene, Cambridge, MA) was digested with BsaI, and the linearized vector was gel-purified. Thereby knockout mice model was established and bred.
Cell isolation and culture
Cells were grown in low glucose Dullbecco modified Eagle medium (DMEM) containing 10% FBS (Gibico) and antibiotics (penicillin and streptomycin). CFs were detached with 0.1% trypsin (Gibico) for passaging and 2 to 3 passages were used to study. Mechanic stretching of cells was conducted as described previously (Komuro et al., 1990) . In brief, CMs were plated at a field density of 4×10 5 cells/ml on or silicone rubber culture dishes (20×40 mm) with 2 ml of culture medium. The culture medium was changed to serum free 12h before stretching. CMs were stretched by 20% with steel-made equipment.
Similarly, CFs were plated at 3×10 5 cells/ml and stretched as CMs. Adult mouse cardiac fibroblasts were isolated by differential adhesion from the single-cell suspensions of the hearts. The single-cell suspensions were obtained using the gentle MACS TM Dissociator (MACS).
Quantitation of mRNA and miRNA Expression
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Northern blot analysis
For northern blot analyses, 15 μg of total RNA were separated on a denaturing 15% polyacrylamide gel and transferred to NYTRAN®N membranes (Whatman) by a semi-dry electroblotting apparatus.
Prehybridization was carried out for 40 min at 42℃ using ULTRAhyb-Oligo Hybridization Buffer (Ambion). Hybridization was carried out in the presence of 5'end-labeled LNA probe with biotin for miR-378 for 4hr. A probe U6, a ubiquitously expressed miRNA, was used as a loading control. After washing, the blots were exposed to visualized on LAS-3000 Imaging System (Fuji)
Histological analysis
Heart tissues were fixed in 10% formalin and embedded in paraffin or frozen in cryomolds, sectioned at 4μm thickness and stained with hematoxylin and eosin (H-E), Masson trichrome and antibodies against collagen I(Abcam), collagen III(Abcam) and α-SMA(Abcam). For measurement, five random highpower fields from each section were chosen and quantified in a blinded manner. The extent of fibrosis was measured in 5 sections from each heart.
Transfection of miRNA mimics and inhibitors.
CMs or CFs were switched into serum-free medium for 24hr prior to tansfection. The siPORT™ NeoFX™ Transfection Agent (Ambion) was used to transfect cells with mirVana™ miR-378 Mimics
